Tepezza was studied in two trials that included about 200 people with thyroid eye disease. People included in the study had bulging eyes (exophthalmos) and most (73%) also had double vision ...

Tepezza is used in adults to treat TED.With TED, your immune system attacks the muscle and fat tissue behind your eyes. This can cause bulging eyes, eye pain and redness, and double vision.TED may ...

Tepezza is a medication used to treat eye bulging, double vision and symptoms of thyroid eye disease such as swelling, redness and eye pain. The prescription medication is delivered as an infusion ...

Tepezza is a prescription drug used to treat thyroid eye disease. Learn about the common, mild, and serious side effects it can cause and how to manage them.

The Indications and Usage section of the Tepezza ® (teprotumumab-trbw) prescribing information has been updated to specify its use for the treatment of thyroid eye disease regardless of thyroid ...

Tepezza (teprotumumab-trbw) is a prescription drug used to treat thyroid eye disease. Tepezza’s cost may depend on factors such as your dosage, whether you have health insurance, and the ...

TEPEZZA, as the first FDA-approved treatment for thyroid eye disease, marks a major breakthrough in managing TED, addressing a critical medical gap for patients who have long had few treatment ...

TEPEZZA received orphan drug designation in Japan, which provided a nine-month regulatory review period compared to the standard 12-month review. The approval was based on the positive results of ...

Further, Tepezza can increase blood glucose, and patients may experience hyperglycemia. Most notably, the company explained that the most common adverse reactions are muscle spasms, nausea ...

IGF-1R antibodies like Tepezza, veligrotug, and eventually VRDN-003, have a fixed duration treatment course. In Tepezza’s case, the treatment lasts 8 infusions or 24 weeks in total ...